Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study on Fetal Growth Restriction Complicated by Early Flowmetric Alterations. ARDEF Adverse or Reverse End Diastolic Flow

NCT06717555 is registered in ClinicalTrials.gov with IRCCS Azienda Ospedaliero-Universitaria di Bologna as lead sponsor.

NCT NCT06717555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06717555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study on Fetal Growth Restriction Complicated by Early Flowmetric Alterations. ARDEF Adverse or Reverse End Diastolic Flow
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase
Observational
Overall status
Completed
Start date
May 15, 2021
Completion date
December 31, 2023
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth restriction (fgr)